# Photronics Inc: Form 10-Q for the period ended Jan 27, 2019

- Company: [Photronics Inc](/companies/plab.md) (CIK 810136)
- Form: 10-Q
- Filed: 2019-03-08
- Accepted by EDGAR: Mar 8, 2019, 16:21 ET
- Period: 2019-01-27
- Accession: 0001140361-19-004608
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/810136/000114036119004608/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/810136/000114036119004608/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-01-27.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-11-01 to 2019-01-27 | $124.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-11-01 to 2019-01-27 | $98.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-11-01 to 2019-01-27 | $26.1m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-11-01 to 2019-01-27 | $4.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-11-01 to 2019-01-27 | $13.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-11-01 to 2019-01-27 | $8.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-11-01 to 2019-01-27 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-11-01 to 2019-01-27 | $5.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-11-01 to 2019-01-27 | $0.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-11-01 to 2019-01-27 | $0.08 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-11-01 to 2019-01-27 | 67,047,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-11-01 to 2019-01-27 | −$19.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2018-11-01 to 2019-01-27 | $106.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2018-11-01 to 2019-01-27 | $10.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-01-27 | $232.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-01-27 | $453.0m | us-gaap:AssetsCurrent |
| Total assets | at 2019-01-27 | $1.15bn | us-gaap:Assets |
| Current liabilities | at 2019-01-27 | $194.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-01-27 | $232.7m | us-gaap:Liabilities |
| Long-term debt | at 2019-01-27 | $24.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-01-27 | $57.9m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2019-01-27 | $3.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2019-01-27 | $761.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 29,714 characters.

### Overview

Management’s discussion and analysis (“MD&A”) of the Company’s financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company’s Annual Report on Form 10-K for the fiscal 2018 year), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor and FPD designers and manufacturers. Photomask technology is also being applied to the fabrication of other higher performance electronic products such as photonics, micro-electronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the micro-electronic industry's migration to more advanced product innovation, design methodologies and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within 24 hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

In the first quarter of fiscal 2019, PDMC, the Company’s majority owned subsidiary in Taiwan, paid a dividend, of which 49.99%, or approximately $26.1 million, was paid to noncontrolling interests.

In the first quarter of 2019, Xiamen American Japan Photronics Mask Co., Ltd. (“PDMCX”), an indirect majority owned joint venture subsidiary of Photronics, Inc., was approved for credit of $50 million, subject to certain limitations related to PDMCX registered capital at the time of borrowing, pursuant to which PDMCX will enter into separate loan agreements (“the Project Loans”) for each borrowing. The Project Loans, which are denominated in renminbi, are being used to finance certain capital expenditures in China. PDMCX has agreed to grant a lien on the land, building and certain equipment owned by PDMCX as collateral for the Project Loans. As of January 27, 2019, PDMCX had borrowed $14.8 million against this approval. This borrowing will be repaid in semiannual installments, which will commence in June 2020 and end in December 2022. In February 2019, PDMCX borrowed an additional $11.4 million, which will be repaid semiannually; repayments will commence in June 2023 and end in December 2025. The interest rates on the Project Loans are based on the benchmark lending rate of the People’s Bank of China (4.9% at January 27, 2019). Interest incurred on these loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.

In the first quarter of 2019, PDMCX was approved for credit of $25.0 million, subject to certain limitations related to PDMCX registered capital at the time of borrowing, pursuant to which PDMCX may enter into separate loan agreements. No guarantees are required as part of this approval. As of January 27, 2019, PDMCX had borrowed $13.8 million against this approval of which $3.7 million were 90-day loans. The remaining $10.1 million borrowed (the “Working Capital Loans”) is to be repaid semiannually from the dates of the individual borrowings, with repayments commencing in May 2019 and ending in January 2022. The 90-day loans were repaid in our second quarter of 2019. These loans, which are denominated in renminbi and U.S. dollars are being used for general financing purposes, including payments of import and value added taxes. The interest rates on the 90-day loans were the market rate on the date of issuance (4.9%), and interest rates on the Working Capital Loans are approximately 5%, and are based on the RMB Loan Prime Rate of the National Interbank Funding Center, plus a spread of 67.75 basis points. Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.

In the fourth quarter of fiscal 2018, we entered into an amended and restated credit agreement (“the new agreement”) that expires in September 2023. The new agreement, which replaced our prior credit agreement, has a $50 million borrowing limit, and a $50 million expansion capacity, which represents a $25 million increase over the previous credit agreement. The new agreement is secured by substantially all of our assets located in the United States and common stock we own in certain of our foreign subsidiaries, and limits the amount we can pay in cash dividends on Photronics, Inc. stock. The new agreement contains the following financial covenants: minimum interest coverage ratio, total leverage ratio and minimum unrestricted cash balance, all of which we were in compliance with at January 27, 2019. We had no outstanding borrowings against the new agreement at January 27, 2019, and $50 million was available for borrowing. The interest rate on the new agreement (2.5% at January 27, 2019) is based on our total leverage ratio at LIBOR plus a spread, as defined in the credit agreement.

In the fourth quarter of fiscal 2018, the Company’s Board of Directors authorized the repurchase of up to $25 million of its common stock, to be executed in open-market transactions or in accordance with a repurchase plan under rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced, under 10b5-1, on October 22, 2018, and expired on February 1, 2019. As of January 27, 2019, we had repurchased 1.5 million shares at a cost of $13.8 million (an average of $9.41 per share) under this program. The number of shares repurchased is subject to market conditions, and our continual evaluation of the optimal use of our cash.

In the first quarter of fiscal 2018, we announced the successful closing of the China joint venture agreement with Dai Nippon Printing Co., Ltd. (“DNP”), which we had agreed to enter into and announced in the third quarter of fiscal 2017 (see discussion below). Under the agreement, our wholly-owned Singapore subsidiary owns 50.01% of the joint venture, which is named Photronics DNP Mask Corporation Xiamen (PDMCX), and a subsidiary of DNP owns the remaining 49.99%. The financial results of the joint venture are included in the Photronics, Inc. consolidated financial statements. See Note 4 of the condensed consolidated financial statements for additional information on the joint venture.

In the fourth quarter of fiscal 2017, we announced that Photronics UK, Ltd., a wholly-owned subsidiary of ours, signed an investment agreement with Hefei State Hi-tech Industry Development Zone to establish a manufacturing facility in Hefei, China. Under the terms of the agreement, through our subsidiary, we will invest a minimum of $160 million, a portion of which may be funded with local borrowings, to build and operate a research and development and manufacturing facility for high-end and mainstream FPD photomasks. As of January 27, 2019, we had invested $53 million in this facility. Hefei State Hi-tech Industry Development Zone will provide certain investment incentives and support for this facility, which will have initial capability to produce up to G10.5+ large area masks and AMOLED products. Construction of this facility was completed in late 2018, and production is anticipated to begin in the first half of 2019.

In the fourth quarter of 2016, Photronics Singapore Pte, Ltd., a wholly-owned subsidiary, signed an investment agreement with the Administrative Committee of Xiamen Torch Hi-Tech Industrial Development Zone (Xiamen Torch) to establish an IC manufacturing facility in Xiamen, China. Under the terms of the agreement, we will build and operate an IC facility to engage in research and development, manufacture and sale of photomasks, in return for which Xiamen Torch will provide certain investment incentives and support. This expansion is also substantially supported by customer commitments for its output. As discussed above, in the first quarter of fiscal 2018, we entered into a joint venture agreement with DNP, under which they hold a 49.99% ownership interest in this investment. The total investment per the agreement is $160 million, of which approximately $32 million remained for Photronics as of January 27, 2019, and will be funded over the next several years with cash and local borrowings. Construction began in 2017 and production is anticipated to start in the second half of 2019.

### Material Changes in Results of Operations

### Three Months ended January 27, 2019, October 31, 2018 and January 28, 2018

The following table represents selected operating information expressed as a percentage of net sales.

|  | Three Months Ended January 27, 2019 | October 31, 2018 | January 28, 2018 |
| --- | ---: | ---: | ---: |
| Revenue | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 79.1 | 75.5 | 77.6 |
| Gross profit | 20.9 | 24.5 | 22.4 |
| Selling, general and administrative expenses | 11.0 | 9.3 | 9.5 |
| Research and development expenses | 3.4 | 2.7 | 3.3 |
| Operating income | 6.5 | 12.5 | 9.6 |
| Other income (expense), net | 0.8 | 1.5 | (3.4) |
| Income before income taxes | 7.3 | 14.0 | 6.2 |
| Income tax (provision) benefit | (1.1) | (2.4) | 1.5 |
| Net income | 6.2 | 11.6 | 7.7 |
| Net income attributable to noncontrolling interests | 2.0 | 3.0 | 2.9 |
| Net income attributable to Photronics, Inc. shareholders | 4.2% | 8.6% | 4.8% |

Note: All of the following tabular comparisons, unless otherwise indicated, are for the three months ended January 27, 2019 (Q1 FY19), October 31, 2018 (Q4 FY18) and January 28, 2018 (Q1 FY18) in millions of dollars.

### Revenue

| IC | Q1 FY19 from Q4 FY18 Revenue in Q1 FY19 | Percent Change | Increase (Decrease) | Q1 FY19 from Q1 FY18 Revenue in Q1 FY19 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| High-end | $34.6 | (12.3)% | $(4.9) | $34.6 | 3.6% | $1.2 |
| Mainstream | 60.3 | (15.6)% | (11.1) | 60.3 | (3.2)% | (2.0) |
| Total | $94.9 | (14.4)% | $(16.0) | $94.9 | (0.8)% | $(0.8) |
| FPD |  |  |  |  |  |  |
| High-end | $21.5 | (2.5)% | $(0.5) | $21.5 | 14.3% | $2.7 |
| Mainstream | 8.3 | (28.9)% | (3.5) | 8.3 | (6.9)% | (0.6) |
| Total | $29.8 | (11.7)% | $(4.0) | $29.8 | 7.4% | $2.1 |
| Total Revenue | $124.7 | (13.8)% | $(20.0) | $124.7 | 1.0% | $1.3 |

24

The following tables compare revenue in Q1 FY19 with revenue in Q4 FY18 and Q1 FY18 by geographic area:

|  | Q1 FY19 from Q4 FY18 Revenue in Q1 FY19 | Percent Change | Increase (Decrease) | Q1 FY19 from Q1 FY18 Revenue in Q1 FY19 | Percent Change | Increase (Decrease) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Taiwan | $57.7 | (7.3)% | $(4.6) | $57.7 | 2.1% | $1.2 |
| Korea | 35.2 | (13.5)% | (5.5) | 35.2 | 6.8% | 2.2 |
| United States | 22.5 | (26.8)% | (8.2) | 22.5 | (10.2)% | (2.5) |
| Europe | 8.4 | (14.5)% | (1.4) | 8.4 | (1.5)% | (0.1) |
| Other | 0.9 | (19.0)% | (0.2) | 0.9 | 143.6% | 0.5 |
|  | $124.7 | (13.8)% | $(19.9) | $124.7 | 1.0% | $1.3 |

Our quarterly revenues can be affected by the seasonal purchasing tendencies of our customers. As a result, demand for our products is typically negatively impacted during the first, and sometimes the second, quarters of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

Revenue decreased 13.8% in Q1 FY19, compared with Q4 FY18, due to seasonal softness and macroeconomic headwinds. There were also six fewer days in the first quarter of our fiscal 2019 than in the fourth quarter of fiscal 2018, due to our adoption of October 31 as the Company’s fiscal year-end. Overall IC and FPD revenues decreased 14.4% and 11.7% respectively. The decrease in mainstream IC of 15.6% was mostly in Asia, particularly Taiwan and China, where macro uncertainty delayed our customers’ initiatives to design new products. The decrease in high-end IC photomasks of 12.3% was due to declines in both logic, as new designs for advanced applications such as smartphones decreased, and memory, due to the postponements of orders from a large customer. Mainstream FPD decreased 28.9%, as we devoted a greater portion of our mainstream capacity to building the non-critical layers of AMOLED mask sets. This redirection of our resources was also in response to competitive pressures that resulted from an over-supplied market. High-end FPD revenues decreased 2.5% as a result of softer demand for G8.5 masks used for large LCD TVs. High-end photomask applications include mask sets for 28 nanometer and smaller products, and G8 and above and active matrix organic light-emitting diode (AMOLED) display technologies for FPD products. High-end photomasks typically have higher selling prices than mainstream products.

Revenue increased 1.0% in Q1 FY19, compared with Q1 FY18, primarily due to increased high-end FPD and IC revenues, which were partially offset by decreased mainstream IC and FPD sales. High-end FPD increased 14.3% due to AMOLED growth, which was the result of an overall increase in industry demand from the prior year’s quarter. High-end IC increased 3.6% due to stronger logic demand. Mainstream IC decreased 3.2%, as demand was softer. Mainstream FPD decreased 6.9% due to a decline in demand for G8.5 masks used for large-screen TVs, and lower demand for LTPS LCD screens in mobile applications.

We expect our FPD revenues to increase in our second quarter, primarily as a result of increased demand for mobile displays. We plan to support our customers’ enhanced requirements with additional capacity we will bring on-line in China. With respect to our IC business, we expect to see a pick-up in memory demand and, while we do not expect to see a material deterioration in logic, believe that a recovery in logic may occur beyond the second quarter.

### Gross Profit

|  | Three Months Ended Q1 FY19 | Q4 FY18 | Percent Change | Q1 FY18 | Percent Change |
| --- | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $26.1 | $35.4 | (26.3)% | $27.7 | (5.6)% |
| Gross margin | 20.9% | 24.5% |  | 22.4% |  |

Gross profit and gross margin decreased in Q1 FY19 from Q4 FY18 primarily as a result of decreased revenue, the effects of which were partially mitigated by decreased material costs and overhead costs of $7.5 million and $3.7 million, respectively. Gross profit and gross margin decreased in Q1 FY19, compared with Q1 FY18, primarily due to increased compensation and related benefits expense and overhead costs of $2.6 million and of $0.8 million, respectively, which were partially offset by decreased material costs of $0.5 million. As we operate in a high fixed cost environment, increases or decreases in our revenues and capacity utilization will generally positively or negatively impact our gross margin.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $0.3 million, or 2.1%, to $13.8 million in Q1 FY19, from $13.5 million in Q4 FY18, primarily due to a $0.3 million decrease in bad debt recoveries from the prior quarter. Selling, general and administrative expenses increased in Q1 FY19 by $2.0 million, or 17.4%, from $11.8 million in Q1 FY18, primarily as a result of increased compensation and related benefits of $1.4 million and increased freight expenses of $0.4 million, which increased as a result of increased sales to China.

### Research and Development

In the U.S., research and development expenses consist of development efforts related to high-end process technologies for 28nm and smaller IC nodes, while in Asia, in addition to the focus on high-end IC technology nodes, G8 and above FPDs and AMOLED applications are also under development.

Research and development expense increased $0.4 million to $4.3 million in Q1 FY19, or 9.1%, from Q4 FY18, primarily as a result of increased development activities in the U.S. Research and development expense was up moderately ($0.2 million, or 3.9%) in Q1 FY19 from Q1 FY18, with increased spending in Taiwan exceeding decreased expenditures and related activities on large area masks in Korea.

### Other Income (Expense), net

|  | Three Months Ended Q1 FY19 | Q4 FY18 | Q1 FY18 |
| --- | ---: | ---: | ---: |
| Interest income and other income (expense), net | $1.6 | $2.9 | $(3.5) |
| Interest expense | (0.5) | (0.6) | (0.6) |
| Other income (expense), net | $1.1 | $2.3 | $(4.1) |

Other income (expense), net decreased in Q1 FY19 by $1.2 million from Q4 FY18. The decrease was primarily the result of reduced foreign currency gains and interest income of $0.6 million and $0.3 million, respectively, in the current quarter, and gains recorded on the sale of long-lived assets recorded in Q4 FY18 of $0.4 million. Other income (expense), net increased in Q1 FY19 by $5.2 million from Q1 FY18, primarily due to foreign currency gains experienced in the current quarter, in contrast to unfavorable foreign currency results in the prior year quarter, with a net effect of $5.7 million. Reduced interest income of $0.3 million partially offset the favorable impact of the foreign currency results.

### Income Tax Provision

|  | Three Months Ended Q1 FY19 | Q4 FY18 | Q1 FY18 |
| --- | ---: | ---: | ---: |
| Income tax benefit (provision) | $(1.4) | $(3.6) | $1.8 |
| Effective income tax rate | 15.2% | 17.5% | (23.1)% |

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances. The effective income tax rate decreased in Q1 FY19, compared with Q4 FY18, is primarily attributable to the net decrease in tax accruals no longer required as a result of the settlement of a non-U.S. income tax audit. The effective income tax rate increase in Q1 FY19, compared with Q1 FY18, is primarily attributable to Q1 FY18 benefits related to the recognition of $3.9 million of previously unrecognized deferred tax benefits associated with alternative minimum tax credits that resulted from the U.S. Tax Cuts and Jobs Act, which was signed into law on December 22, 2017, and an increase of deferred tax assets of $0.2 million, which was the result of an increase in the Taiwan corporate tax rate.

### Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $2.5 million in Q1 FY19, which represented a decrease of $1.8 million and $1.1 million from Q4 FY18 and Q1 FY18, respectively. The changes from both comparative periods were due to decreased net income at our IC manufacturing facility in Taiwan, in which we hold a 50.01% ownership interest.

### Liquidity and Capital Resources

Our working capital at the end of Q1 FY19 was $258.5 million, compared with $311.7 million at the end of Q4 FY18, and our cash and cash equivalents decreased in Q1 FY19 by $96.8 million from $329.3 million at October 31, 2018. Cash flows related to operating activities decreased $50.1 million to $19.3 million used in Q1 FY19 from $30.9 million provided in Q1 FY18. In addition to the decrease in net income of $1.7 million from the prior year’s quarter, significant contributors to the decrease in cash flows from operating activities in Q1 FY19, compared with Q1 FY18, were increases in accounts receivable of $14.0 million and other current assets of $22.5 million, a significant cause of which was an increase in recoverable value added taxes related to our investments in China. Decreased accounts payable of $6.3 million also contributed to the year-over-year decrease in operating cash flows.

Net cash used in investing activities was $101.9 million in Q1 FY19, an increase of $90.7 million from the $11.1 million used in Q1 FY18. The increase was primarily attributable to increased capital expenditures of $92.9, the preponderance of which related to building and equipping our China facilities. Cash flows provided by financing activities increased from $11.2 million in Q1 FY18 to $21.4 million in Q1 FY19. The increase was primarily the result of proceeds from contributions from DNP of $29.4 million to PDMCX (in which they hold a 49.99% interest) and the receipt of debt proceeds by PDMCX of $28.2 million, the effects of which were partially offset by dividends paid to DNP of $26.1 million (related to their 49.99 percent interest in our IC facility in Taiwan), and $10.7 million used to acquire our common stock under a share repurchase program. Favorable effects of foreign currency exchange rates contributed $3.0 million and $9.8 million to the changes in cash balances in Q1 FY19 and Q1 FY18, respectively.

As of January 27, 2019, and October 31, 2018, our total cash and cash equivalents included $195.7 million and $244.5 million, respectively, held by our foreign subsidiaries. The majority of earnings of our foreign subsidiaries are considered to be indefinitely reinvested. Repatriation of these funds to the U.S. may subject them to U.S. state income taxes and local country withholding taxes in certain jurisdictions. Our foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.

As of January 27, 2019, we had capital commitments outstanding of approximately $38 million, nearly all of which related to building and equipping our China facilities (discussed below). We intend to finance our capital expenditures with our working capital, cash generated from operations and, if necessary, additional borrowings. We have entered into a joint venture that is constructing an IC facility in China with an estimated total joint investment of $160 million. Our remaining funding commitment for the joint venture is approximately $32 million which we will fulfill over the next several quarters. We have also commenced construction of an FPD facility in China in which, as of January 27, 2019, we have invested $53 million. We believe that our cash on hand, cash generated from operations and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. We regularly review the availability and terms at which we might issue additional equity or debt securities in the public or private markets. However, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our capital requirements exceed our existing cash, cash generated by operations, and cash available under our credit facilities.

Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). Depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit facility.

### Off-Balance Sheet Arrangements

In January 2018, Photronics, through its wholly-owned Singapore subsidiary, and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Photronics DNP Mask Corporation Xiamen” (“PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the Joint Venture Operating Agreement of Photronics DNP Mask Corporation Xiamen (“the Agreement”), DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two year term of the Agreement that cannot be resolved between the two parties. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of January 27, 2019, Photronics and DNP each had net investments in PDMCX of $44.9 million.

We lease certain office facilities and equipment under operating leases that may require us to pay taxes, insurance and maintenance expenses related to the properties. Certain of these leases contain renewal or purchase options exercisable at the end of the lease terms.

### Business Outlook

A majority of our revenue growth is expected to continue to come from the Asia region, predominantly in China. In response to this expectation, we have entered into a joint venture that completed the construction of an IC research and development and manufacturing facility in Xiamen, China, in late 2018. Production is anticipated to begin at this facility in the second half of 2019. In addition, in August 2017, we entered into an investment agreement to construct an FPD manufacturing facility in Hefei, China. Construction of this facility was completed in late 2018, and production is anticipated to begin in the first half of 2019.

We make continual assessments of our global manufacturing strategy and monitor our revenue and related cash flows from operations. This ongoing assessment could result in future facility closures, asset redeployments, additional impairments of intangible or long-lived assets, workforce reductions, or the addition of increased manufacturing facilities, all of which would be based on market conditions and customer requirements.

Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties. While various risks and uncertainties were discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 31, 2018, a number of other unforeseen factors could cause actual results to differ materially from our expectations.

### Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 14 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

## Market risk

As filed, 2,491 characters.

### Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we have transactions and balances in Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell and collect for products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

As of January 27, 2019, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $29.0 million, which represents an increase of $15.8 million from our exposure at October 31, 2018. The increase in foreign currency rate change risk is primarily the result of increased exposures of the Chinese renminbi and South Korean won, against the U.S. dollar. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese Yen, would have had a material effect on our January 27, 2019, condensed consolidated financial statements.

### Interest Rate Risk

A 10% change in interest rates on our variable rate borrowings would not have had a material effect on our consolidated financial positions, results of operations, or cash flow in the three month period ended January 27, 2019.

## Controls and procedures

As filed, 1,942 characters.

### Evaluation of Disclosure Controls and Procedures

We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), designed to provide reasonable assurance that information required to be disclosed in its reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the first quarter of fiscal year 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 155 characters.

There have been no material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Form 10-K for the year ended October 31, 2018.

Filed Mar 8, 2019.
Source: SEC EDGAR, the filing index for accession 0001140361-19-004608. Last ingested by Listed: Nov 15, 2026, 01:00 ET. No prices; not investment advice.
